ArticleIDCases2026
Esophageal leishmaniasis presenting as multiple lower esophageal masses and the first manifestation of advanced HIV infection: A case report.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visceral leishmaniasis is a vector-borne disease caused by protozoan parasites of the genus Leishmania and is endemic in parts of East Africa, including Ethiopia. Coinfection with HIV is associated with atypical clinical manifestations, reduced serologic sensitivity, and frequent relapse. We describe a 48-year-old Ethiopian man with a five-month history of dysphagia, odynophagia, and progressive weight loss. Examination revealed hepatosplenomegaly, and laboratory testing showed anemia and thrombocytopenia. Upper gastrointestinal endoscopy demonstrated multiple ulcerated, mass-like growths of the lower esophagus causing luminal narrowing; biopsy revealed numerous Leishmania amastigotes exhibiting the "marquee sign." Splenic and bone marrow aspirates were negative for parasites. Subsequent HIV testing was positive, with a CD4 + count of 133 cells/µL, representing the first indication of previously undiagnosed HIV infection. The patient was treated with intravenous liposomal amphotericin B and antiretroviral therapy, with marked clinical improvement; repeat endoscopy and biopsy after treatment showed resolution of the esophageal lesions and clearance of the parasite. This case illustrates that esophageal involvement, although rare, may be the initial presentation of visceral leishmaniasis and can unmask previously undiagnosed advanced HIV infection. Clinicians practicing in leishmania-endemic regions should consider this diagnosis in patients with unexplained esophageal masses, particularly when biopsies for malignancy are inconclusive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.